Search
Home
Products
Romidepsin
Romidepsin WeChat WhatsApp
Product Name Romidepsin
Price: Inquiry
Catalog No.: CN00556
CAS No.: 128517-07-7
Molecular Formula: C24H36N4O6S2
Molecular Weight: 540.7 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Source:
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
SMILES: C/C=C/1NC(=O)[C@H]2CSSCC/C=C/[C@@H](OC(=O)[C@@H](NC1=O)C(C)C)CC(=O)N[C@@H](C(=O)N2)C(C)C
Contact us
First Name:
Last Name:
E-mail:
Question:
Description Romidepsin is a potent HDAC1 and HDAC2 inhibitor with IC50s of 36 and 47 nM, respectively.
Target HDAC1:36 nM (IC50) HDAC2:47 nM (IC50) HDAC4:510 nM (IC50) HDAC6:14000 nM (IC50)
In Vitro Romidepsin potently inhibits HDAC1 and HDAC2 (IC50=36, 47 nM, respectively). Romidepsin has slightly inhibitory effects against HDAC4 and HDAC6 (IC50=510, 14000 nM, respectively). Romidepsin induces histone acetylation and p21 expression with an EC50 of 3.0 nM. Romidepsin is more strongly than redFK with EC50 of 11 nM due to the instability of redFK in HeLa cells[1]. Romidepsin is 100 times more potent than TSA and 1,000,000 times more potent than butyrate in inhibiting the proliferation of the A549 cells. Romidepsin causes mitotic arrest, and that the treatment with HDIs causes defects in chromosome segregation in mitosis[2]. Romidepsin inhibits the growth of U-937, K562, and CCRF-CEM cells with IC50 values of 5.92 nM, 8.36 nM, and 6.95 nM, respectively[3].
In Vivo In a scid mouse lymphoma model, romidepsin treated mice once or twice a week survive longer than control mice, with median survival times of 30.5 (0.56 mg/kg) and 33 days (0.32 mg/kg), respectively (vs. 20 days in control mice). Remarkably, 2 out of 12 mice treated with romidepsin (0.56 mg/kg once or twice a week) survive past the observation period of 60 days. The apoptotic population of U-937 cells increases to 37.7% after 48 hr of treatment with romidepsin in a time dependent manner. In addition, romidepsin induces G1 and G2/M arrest and the differentiation of U-937 cells to the CD11b(+)/CD14(+) phenotype. Expression of p21(WAF1/Cip1) and gelsolin mRNA increases up to 654- and 152-fold, respectively, after 24 hr of treatment with romidepsin. Romidepsin causes histone acetylation in p21(WAF1/Cip1) promoter regions, including the Sp1-binding sites[3].
Cell Assay Cells are exposed to various concentrations of Romidepsin for 72 hours in 96-well plates. 20 μL of 5 mg/mL MTT solution in PBS is added to each well for 4 hours. After removal of the medium, 170 μL of DMSO is added to each well to dissolve the formazan crystals. The absorbance at 540 nm is determined. In addition, cells are incubated with trypan blue, and the numbers of blue (dead) cells and transparent (live) cells are counted in a hemocytometer. For cell cycle analysis, cells are incubated for 30 minutes in propidium iodide staining solution containing 0.05 mg/mL propidium iodide, 1 mM EDTA, 0.1% Triton X-100, and 1 mg/mL RNase A in PBS. The suspension is then passed through a nylon mesh filter and analyzed on a Becton Dickinson FACScan.
Animal Admin Briefly, male scidmice are injected i.p. with 150 mg/kg of cyclophosphamide. All the mice injected with cyclophosphamide alone survive over the observation period. Twenty-four hours after cyclophosphamide injection, mice are inoculated i.p. with 1×107 U-937 cells in 500 μL PBS. Twenty-four hours after tumor cell inoculation, the mice are treated i.p. with or without FK228 at doses ranging from 0.1 to 1 mg/kg, once or twice a week. Control mice are treated with 10% HCO60 saline twice a week. Six and twelve mice are used for FK228-treated and control groups, respectively. The observation period is 60 days after cell inoculation, and the antitumor effect is evaluated by survival time, which is analyzed for statistical significance by Peto’s test.
Density1.2±0.1 g/cm3
Boiling Point942.8±65.0 °C at 760 mmHg
Flash Point524.0±34.3 °C
Exact Mass540.207642
PSA193.30000
LogP0.95
Vapour Pressure0.0±0.3 mmHg at 25°C
Storage conditionAmber Vial, -20°C Freezer, Under Inert Atmosphere